Hepatitis C infection is not associated with an increased risk of acute liver allograft rejection.
McLaughlin
K
K
Department of Medicine, London Health Sciences Centre and University of Western Ontario, London, Ontario, Canada.
Rizkalla
K S
KS
Adams
P C
PC
Grant
D R
DR
Wall
W J
WJ
Jevnikar
A M
AM
Marotta
P J
PJ
D000208:Acute Disease; D000328:Adult; D000368:Aged; D019992:Databases as Topic; D018572:Disease-Free Survival; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology*; D006085:Graft Survival; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D017093:Liver Failure / Q000209:etiology / Q000601:surgery*; D016031:Liver Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D013997:Time Factors
D007166:Immunosuppressive Agents